Subsequently, the researchers have shed more light on not only the CDK4/6 inhibitor in many other types of cancer but also other members of CDKs (Min et al., 2018; Ding et al., 2020; Álvarez-Fernández and Malumbres, 2020). Here, CDK4 is linked to cancer.